CEQUA showed significant improvement in different dry eye outcome measures1-3

CEQUA was studied in two 12-week, randomized, vehicle-controlled trials1

View the study design

Significant improvement in tear production at 3 months1

A higher proportion of eyes demonstrated significant improvement (≥10 mm) from baseline in Schirmer score with CEQUA vs vehicle1

Study 1

16.8% vs 8.6%

P<0.01

Study 2

16.6% vs 9.2%

P<0.01

See more about the difference in tear production

Patients treated with CEQUA produced more tears2

Across 2 studies, patients treated with CEQUA produced approximately 2-3 mm more tears compared with patients treated with vehicle (Study 1, 3.5 mm vs 0.4 mm; Study 2, 2.80 mm vs 0.99 mm)

Significant improvement in total conjunctival staining2,3

Chart of Study 2 results
  • Study 1 found similar results at Day 84 (mean reduction from baseline: -1.9 vs -1.4 with vehicle, P<0.05)2

Read the published journal articles that evaluated the safety and efficacy of CEQUA:

Significant reduction in central and total corneal staining2,3

Central corneal staining

Chart of Study 2 results
  • At baseline, only 38.3% and 37.5% had complete clearing with CEQUA and vehicle, respectively2

Total corneal staining

Chart of Study 2 results
  • Study 1 found similar results at Days 28 and 842
    • Day 28: Mean reduction from baseline: -1.1 vs -0.5 with vehicle, P<0.05
    • Day 84: Mean reduction from baseline: -1.7 vs -0.9 with vehicle, P<0.01